ArticleCell reports2018

Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks.

Juan Bayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.